Search research articles
Contact Us
Filters
Showing results (21-30 of 70) with videos related to
Page
of 7
Sort By:
Molecular Pharmaceutics
|
February 6, 2007
Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance
Robert F Battisti, Yanqiang Zhong, Lanyan Fang, et al.
Journal of Clinical Pharmacology
|
February 5, 2019
Is Bioequivalence Established Based on the Reference-Scaled Average Bioequivalence Approach Relevant to Chronic Administration of Phenytoin? Perspectives Based on Population Pharmacokinetic Modeling and Simulations
Hyewon Kim, Lanyan Fang, Jingyu Yu, et al.
Journal of Clinical Pharmacology
|
May 16, 2019
Physiologically Based Pharmacokinetic Modeling to Evaluate Formulation Factors Influencing Bioequivalence of Metoprolol Extended-Release Products
Sumit Basu, Haitao Yang, Lanyan Fang, et al.
Cancer Chemotherapy and Pharmacology
|
August 15, 2006
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia
Xianhua Cao, Lanyan Fang, Seth Gibbs, et al.
Journal of Medicinal Chemistry
|
November 15, 2008
Histone deacetylase inhibitors through click chemistry
Jie Shen, Robert Woodward, James Patrick Kedenburg, et al.
Clinical Pharmacology and Therapeutics
|
January 25, 2021
Use of Partial Area Under the Curve in Bioavailability or Bioequivalence Assessments: A Regulatory Perspective
Lanyan Fang, Ramana Uppoor, Mingjiang Xu, et al.
Pharmaceutical Research
|
November 6, 2025
Using Lung Regional Deposition Modeling as Model-Integrated Evidence for Locally Acting Orally Inhaled Drug Products
Ross L Walenga, Steven G Chopski, Jae H Lee, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 1, 2022
Mechanistic modeling of drug products applied to the skin: A workshop summary report
Eleftheria Tsakalozou, Khondoker Alam, Priyanka Ghosh, et al.
The AAPS Journal
|
April 22, 2021
Development of a Pediatric Relative Bioavailability/Bioequivalence Database and Identification of Putative Risk Factors Associated With Evaluation of Pediatric Oral Products
Gopal Pawar, Fang Wu, Liang Zhao, et al.
Journal of Pharmaceutical Sciences
|
October 20, 2025
Emerging perspectives on leveraging physiologically based biopharmaceutics modeling (PBBM) for BCS class III biowaivers: A webinar summary
Lanyan Fang, Shereeni Veerasingham, Yunming Xu, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 70) with videos related to
Sort By:
Page
of 7
Molecular Pharmaceutics
|
February 6, 2007
Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance
Robert F Battisti, Yanqiang Zhong, Lanyan Fang, et al.
Journal of Clinical Pharmacology
|
February 5, 2019
Is Bioequivalence Established Based on the Reference-Scaled Average Bioequivalence Approach Relevant to Chronic Administration of Phenytoin? Perspectives Based on Population Pharmacokinetic Modeling and Simulations
Hyewon Kim, Lanyan Fang, Jingyu Yu, et al.
Journal of Clinical Pharmacology
|
May 16, 2019
Physiologically Based Pharmacokinetic Modeling to Evaluate Formulation Factors Influencing Bioequivalence of Metoprolol Extended-Release Products
Sumit Basu, Haitao Yang, Lanyan Fang, et al.
Cancer Chemotherapy and Pharmacology
|
August 15, 2006
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia
Xianhua Cao, Lanyan Fang, Seth Gibbs, et al.
Journal of Medicinal Chemistry
|
November 15, 2008
Histone deacetylase inhibitors through click chemistry
Jie Shen, Robert Woodward, James Patrick Kedenburg, et al.
Clinical Pharmacology and Therapeutics
|
January 25, 2021
Use of Partial Area Under the Curve in Bioavailability or Bioequivalence Assessments: A Regulatory Perspective
Lanyan Fang, Ramana Uppoor, Mingjiang Xu, et al.
Pharmaceutical Research
|
November 6, 2025
Using Lung Regional Deposition Modeling as Model-Integrated Evidence for Locally Acting Orally Inhaled Drug Products
Ross L Walenga, Steven G Chopski, Jae H Lee, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 1, 2022
Mechanistic modeling of drug products applied to the skin: A workshop summary report
Eleftheria Tsakalozou, Khondoker Alam, Priyanka Ghosh, et al.
The AAPS Journal
|
April 22, 2021
Development of a Pediatric Relative Bioavailability/Bioequivalence Database and Identification of Putative Risk Factors Associated With Evaluation of Pediatric Oral Products
Gopal Pawar, Fang Wu, Liang Zhao, et al.
Journal of Pharmaceutical Sciences
|
October 20, 2025
Emerging perspectives on leveraging physiologically based biopharmaceutics modeling (PBBM) for BCS class III biowaivers: A webinar summary
Lanyan Fang, Shereeni Veerasingham, Yunming Xu, et al.
Page
of 7